Novartis AG vs Warner Music Group Corp — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Warner Music Group Corp trades at $25.08 (market cap $13.12B). The key difference: Novartis AG is far larger — about 22.5× Warner Music Group Corp's market cap, and Warner Music Group Corp pays the higher dividend (3.19%). Which is the better fit depends on your goals.
| NVS | WMG | |
|---|---|---|
Market Cap | $295.37B | $13.12B |
Sector | Health | Media |
52-Week High | $168.62 | $34.72 |
52-Week Low | $119.31 | $23.65 |
Enterprise Value | $336.69B | $17.42B |
Dividend Yield | 3.07% | 3.19% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →